Next Article in Journal
The effect of combined treatment methods on survival and toxicity in patients with pancreatic cancer
Previous Article in Journal
Brain natriuretic peptide and other cardiac markers predicting left ventricular remodeling and function two years after myocardial infarction
Medicina is published by MDPI from Volume 54 Issue 1 (2018). Articles in this Issue were published by another publisher in Open Access under a CC-BY (or CC-BY-NC-ND) licence. Articles are hosted by MDPI on mdpi.com as a courtesy and upon agreement with Lithuanian Medical Association, Lithuanian University of Health Sciences, and Vilnius University.
Open AccessArticle

Percutaneous transhepatic biliary stenting: The first experience and results of the Hospital of Kaunas University of Medicine

1
Department of Surgery
2
Institute for Biomedical Research
3
Department of Radiology
4
Institute of Cardiology, Kaunas University of Medicine, Lithuania
*
Author to whom correspondence should be addressed.
Medicina 2008, 44(12), 969; https://doi.org/10.3390/medicina44120121
Received: 15 April 2008 / Accepted: 5 December 2008 / Published: 10 December 2008
Malignant biliary obstruction may be caused by cholangiocarcinoma and other nonbiliary carcinomas. At the time of diagnosis, 90% of patients with malignant obstructive jaundice may benefit from palliative treatment only. The objective of palliation is to relieve jaundice-related symptoms, prevent cholangitis, prolong survival, and improve quality of life. Percutaneous transhepatic biliary stenting is a well-established procedure used in patients with malignant obstruction of intra- and extrahepatic bile ducts. Twelve patients (9 women, 3 men; mean age, 68 years; range, 44–88 years) with inoperable malignant biliary obstruction were selected for percutaneous transhepatic biliary stenting with metallic stents in the period from January to December 2007. Technical and clinical success rate in this patient series was 83% and 80%, respectively. Minor and major complications occurred in 17% and 8% of cases, respectively, which is in the range reported by the others. This is our first experience of percutaneous transhepatic biliary stenting at the Hospital of Kaunas University of Medicine and, to our knowledge, the first reported patient series in Lithuania. These first results encourage expanding effective palliation by the employment of the percutaneous transhepatic biliary stenting in patients with nonresectable malignant biliary obstruction or in case of a recurrent disease after curative surgery. The cost effectiveness of percutaneous transhepatic biliary stenting against percutaneous transhepatic biliary drainage has yet to be evaluated in a prospective manner. However, immediate clinical benefits and positive short-term outcomes are unequivocal.
Keywords: malignant biliary obstruction; percutaneous transhepatic biliary stenting malignant biliary obstruction; percutaneous transhepatic biliary stenting
MDPI and ACS Style

Dambrauskas, Ž.; Paškauskas, S.; Lizdenis, P.; Uktveris, R.; Pranculis, A.; Kaupas, R.S.; Barauskas, G.; Pundzius, J. Percutaneous transhepatic biliary stenting: The first experience and results of the Hospital of Kaunas University of Medicine. Medicina 2008, 44, 969.

Show more citation formats Show less citations formats
Note that from the first issue of 2016, MDPI journals use article numbers instead of page numbers. See further details here.

Article Access Map by Country/Region

1
Only visits after 24 November 2015 are recorded.
Back to TopTop